Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 29'th Dec 2025
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present
Critical Analysis: 10x Genomics (NASDAQ:TXG) & iRhythm Technologies (NASDAQ:IRTC)
02:16am, Saturday, 27'th Dec 2025
10x Genomics (NASDAQ: TXG - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two com
Aaron Wealth Advisors LLC Invests $462,000 in 10x Genomics $TXG
03:09am, Friday, 19'th Dec 2025
Aaron Wealth Advisors LLC purchased a new position in shares of 10x Genomics (NASDAQ: TXG) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Torex Gold Resources (TSE:TXG) Shares Pass Above 200-Day Moving Average – Here’s What Happened
04:00am, Thursday, 18'th Dec 2025
Torex Gold Resources Inc. (TSE: TXG - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$52.17 and traded as high as C$6
Federated Hermes Inc. Has $9.12 Million Holdings in 10x Genomics $TXG
03:52am, Friday, 12'th Dec 2025
Federated Hermes Inc. raised its holdings in shares of 10x Genomics (NASDAQ: TXG) by 665.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
09:00am, Tuesday, 18'th Nov 2025
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY , Nov. 18, 2025 /PRNewswir
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
04:05pm, Tuesday, 11'th Nov 2025
PLEASANTON, Calif. , Nov. 11, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
10x Genomics, Inc. (TXG) Q3 2025 Earnings Call Transcript
10:56pm, Thursday, 06'th Nov 2025
10x Genomics, Inc. ( TXG ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Cassie Corneau - Manager of Investor Relations & Strategic Finance Serge Saxonov - Co-Founder, CEO &
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics
08:01pm, Thursday, 06'th Nov 2025
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics c
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates
06:56pm, Thursday, 06'th Nov 2025
10x Genomics (TXG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago.
10x Genomics Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 06'th Nov 2025
PLEASANTON, Calif. , Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September�
Torex Gold Resources Inc. (TXG:CA) Q3 2025 Earnings Call Transcript
11:56am, Thursday, 06'th Nov 2025
Torex Gold Resources Inc. ( TXG:CA ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Dan Rollins - Senior Vice President of Corporate Development & Investor Relations Jody Kuze
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:07am, Thursday, 30'th Oct 2025
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday
02:42am, Thursday, 30'th Oct 2025
10x Genomics (NASDAQ: TXG - Get Free Report) will likely be announcing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.27
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
09:00am, Wednesday, 29'th Oct 2025
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies PLEASANTON, Calif. , Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, In
